HSTM

HSTM is a slow-and-steady healthcare-SaaS workhorse, not a growth story. Revenue inched up 4.3% to $304M in FY2025 — the fifth straight year of mid-single-digit growth — but net income actually fell 8.3% to $18.3M and diluted EPS slipped to $0.61 from $0.66. Operating margin compressed to 6.7% from ~7.3%, breaking a multi-year up-trend. MD&A is candid about the mix shift behind this: subscription growth in Competency Suite, CredentialStream and ShiftWizard (plus Virsys12 + MissionCare acquisitions) is being partially offset by declines in 'legacy credentialing, scheduling, and content program solutions' and softer demand for 'health equity and belonging content' as customers cut elective spend.

The quality of the business shows up in the cash flow statement, not the income statement. Operating cash flow rose 9.8% to $63.3M against just $3.7M of capex — a ~$59.6M FCF haul on a $769M market cap, roughly 7.7% FCF yield. D&A of $43.5M (largely capitalized software and acquired intangibles) is what makes GAAP EPS look optically expensive. Management is returning capital meaningfully: $30M of buybacks (shares -3.5% YoY) plus a small $3.7M dividend. They also deployed ~$36M on the two 2025 acquisitions, which is why cash dropped 39% to $36.2M and current liabilities ($124M) now slightly exceed current assets ($120M) — not a stress signal, but the cushion is thinner.